Assessing cell viability with the 3D CoSeedis™ Live Cell Detection in chip Assay
Determining cell viability upon compound treatment is an essential step in drug development to assess functionality and effectiveness. The readout of such an assay decides on the fate of a certain test compound and whether or not to progress to clinical trials. It is therefore all the more important that viability data can be collected from reliable and physiologically relevant ex vivo systems.
The 3D CoSeedis™ assay portfolio offers high-content information fast, animal-free and physiologically relevant.
The 3D CoSeedis™ Live Cell Detection in chip Assay delivers highly accurate and reliable information on cell death rates with minimal discrepancies to in vivo observations. It offers:
Statistical relevance through simultaneous readout of up to 680 micro-tissues per condition
Unsurpassed accuracy of test results due to highly homogenous and uniform micro-tissues within 3D CoSeedis™ chips
Live cell imaging
High-throughput sample processing through automation-compatible in chip fluorescent microscopy
Furthermore, the 3D CoSeedis™ Live Cell Detection in chip Assay can be multiplexed with the 3D CoSeedis™ Cytotoxicity in chip and the 3D CoSeedis™ Apoptosis in chip Assays to get a comprehensive data set on drug efficacy and mode of action. Likewise, additional data from the very same 3D cultures can be obtained on drug penetration and localization. The 3D CoSeedis™ assay portfolio therefore offers high-content information fast, animal-free and physiologically relevant.
Are you interested to get to know more about abc biopply’s 3D CoSeedis™ assays? Or would you like to know how our services benefit your drug development process? I am looking forward to receiving your call.
